SGLT-2 inhibitors and high-dose acarbose as potential high-risk
combinations for ketosis and ketoacidosis in Asian patients with T2DM：A
case series
- Wei Qiang,
- Fei Yang
, - Ling Liu,
- Ruiqing Dong,
- Yushi Sun,
- Ahona Mondal,
- Hui Guo
Wei Qiang
The First Affiliated Hospital of Xi'an Jiaotong University
Author ProfileFei Yang
First Affiliated Hospital of Xi'an Medical University
Author ProfileRuiqing Dong
The First Affiliated Hospital of Xi'an Jiaotong University
Author ProfileYushi Sun
The First Affiliated Hospital of Xi'an Jiaotong University
Author ProfileAhona Mondal
The First Affiliated Hospital of Xi'an Jiaotong University
Author Profile20 Mar 2024Submitted to Clinical Case Reports 13 Apr 2024Reviewer(s) Assigned
17 Apr 2024Review(s) Completed, Editorial Evaluation Pending
18 Apr 2024Editorial Decision: Revise Minor
27 Jun 20241st Revision Received
05 Jul 2024Submission Checks Completed
05 Jul 2024Assigned to Editor
09 Jul 2024Review(s) Completed, Editorial Evaluation Pending
09 Jul 2024Editorial Decision: Accept
